Skip to main content
Clinical Trials/NCT03563898
NCT03563898
Unknown
Not Applicable

Feasibility and Safety in the Management of Fluid Overload in Peritoneal Dialysis Patients Through Sweat Stimulation With the Use of Portable Sauna Bath, Pilot Study

Hospital Civil de Guadalajara1 site in 1 country10 target enrollmentMay 28, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Fluid Overload
Sponsor
Hospital Civil de Guadalajara
Enrollment
10
Locations
1
Primary Endpoint
Number of participants with treatment-related adverse events (grade 2 or above) as measured by CTCAE v 4.0
Last Updated
7 years ago

Overview

Brief Summary

The objective of this pilot study is to evaluate the feasibility and safety of the use of diaphoresis achieved through the use of portable sauna baths in peritoneal dialysis patients with fluid overload

Detailed Description

Fluid overload is a common problem in peritoneal dialysis (PD) patients and it is associated with left ventricular hypertrophy and other adverse cardiac consequences. Fluid management is therefore an important aspect in the management of dialysis patient. Despite improvements in dialysis methods and other techniques in these patients, fluid overload persists due to the great limitations of the affected population: physiopathological, economic, educational, social and psychological. The above creates the need for other therapies that lead to the reduction of overload and thus avoid the comorbidity that this entails. The objective of this study is to evaluate the feasibility and safety of the use of diaphoresis achieved through the use of portable sauna baths in peritoneal dialysis patients with fluid overload. The patients are subjected to a period of data collection for 3 days and then use the portable sauna bath 30 minutes a day supervised by the research team during the 6 following days, without interrupting their peritoneal dialysis therapy. We plan to recruit at least 9 patients with PD with fluid overload. Changes in the degree of overhydration are determined by bioimpedance spectroscopy and patient weight at the beginning and end after treatment. Changes in body weight, blood pressure, potassium, urea and creatinine levels, the degree of edema, as well as knowledge about the salt and liquid line were also evaluated. Adverse events will be reported.

Registry
clinicaltrials.gov
Start Date
May 28, 2018
End Date
June 11, 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Pablo Maggiani Aguilera

Principal Investigator

Hospital Civil de Guadalajara

Eligibility Criteria

Inclusion Criteria

  • Being on chronic peritoneal dialysis every day since at least 3 months Diagnostic of Fluid overload Stable clinical condition Written informed consent

Exclusion Criteria

  • Any cardiovascular event in the last 12 months (acute myocardial infarction, NYHA Heart Failure III-IV, Cardiac Arrhythmia, Cerebral Vascular Event, Unstable-Stable Angina) Peritonitis Pregnancy

Outcomes

Primary Outcomes

Number of participants with treatment-related adverse events (grade 2 or above) as measured by CTCAE v 4.0

Time Frame: Through Day 10 of follow up

Discontinuation criteria for CTCAE v 4.0 were grade ≥3 adverse events and even grade ≤2 adverse events if the participant wished to withdraw from the study

Secondary Outcomes

  • Decrease in patient's weight(Through Day 10 of follow up)
  • Decrease in blood pressure(Through Day 10 of follow up)
  • Changes in sleep quality(Through Day 10 of follow up)
  • Decrease in fluid overload symptoms(Through Day 10 of follow up)
  • Degree of overhydration(Through Day 10 of follow up)
  • Decrease in the control of Urea, Creatinine, phosphorus, potassium and calcium levels(Through Day 10 of follow up)

Study Sites (1)

Loading locations...

Similar Trials